Platform
Workflows
Antibody Discovery
Viral Neutralization
Cell Line Development
Cell Therapy Development
Synthetic Biology
Advanced Automation
The Beacon
®
Optofluidic System
The Lightning™ Optofluidic System
The Culture Station™ System
Technology
Company
News
Press Releases
Customer Spotlights
Blog
Events
Investors
Careers
Resources
Support
Get In Touch
Latest
News
News
06.15.20
Optofluidics Aids Cell Line Development for Antibody-Based Therapies
News
06.11.20
Antibody Therapies to Cure Coronavirus Now Under Human Trial Phase
News
05.21.20
Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab
News
05.13.20
The Race Is On to Find the Holy Grail of Covid-19 Antibodies
News
05.11.20
Antibody Shots Could Give Short-Term Doses of COVID-19 Protection. Will They Arrive before a Vaccine?
News
05.08.20
The Hope behind Antibody Treatments as a Quick Coronavirus Fix
News
05.06.20
How to Prevent Another COVID-19? ‘Invest in Infrastructure’
News
05.05.20
Finding the Best Cells for Faster Drug Discovery
News
04.29.20
Apple Founder Zoom-Bombs Meeting To Thank COVID-19 Scientists
News
04.23.20
Company Focuses on Finding Coronavirus Antibodies in Push for New Therapeutics
News
04.23.20
Beyond Testing: The Importance of Antibodies in Tackling Covid-19
News
04.23.20
Ablexis, AlivaMab Discovery Services, and Berkeley Lights Collaborate to Identify a Diverse Panel of Anti-SARS-CoV-2 Human Antibodies
News
04.17.20
Engineering During a Pandemic
News
04.10.20
The Race to Find a Covid-19 Drug in the Blood of Survivors
News
03.25.20
Timeline Shows 3 Paths to COVID-19 Treatment and Prevention
News
03.13.20
How the Coronavirus Validated Berkeley Lights’ Technology and Its Supply Chain
News
02.06.20
GenScript ProBio Screens anti-2019 nCoV Antibodies in Just 24 Hours
News
12.01.19
2019 Top 10 Innovations
1
2
3